96 related articles for article (PubMed ID: 7509751)
1. Blockade of tachykinin NK1 receptors by CP-96345 enhances dopamine release and the striatal dopamine effects of methamphetamine in rats.
Gygi SP; Gibb JW; Johnson M; Hanson GR
Eur J Pharmacol; 1993 Nov; 250(1):177-80. PubMed ID: 7509751
[TBL] [Abstract][Full Text] [Related]
2. Dopamine-mediated changes in central nervous system neurotensin systems: a role for NMDA receptors.
Singh NA; Bush LG; Gibb JW; Hanson GR
Eur J Pharmacol; 1990 Oct; 187(3):337-44. PubMed ID: 2150044
[TBL] [Abstract][Full Text] [Related]
3. Response of extrapyramidal and limbic neuropeptides to fenfluramine administration: comparison with methamphetamine.
Hanson GR; Singh N; Bush L; Gibb JW
J Pharmacol Exp Ther; 1991 Dec; 259(3):1197-202. PubMed ID: 1722253
[TBL] [Abstract][Full Text] [Related]
4. Characterization of dopaminergic influence on striatal-nigral neurotensin systems.
Letter AA; Matsuda LA; Merchant KM; Gibb JW; Hanson GR
Brain Res; 1987 Sep; 422(1):200-3. PubMed ID: 3119151
[TBL] [Abstract][Full Text] [Related]
5. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms.
Reid MS; Herrera-Marschitz M; Hökfelt T; Lindefors N; Persson H; Ungerstedt U
Exp Brain Res; 1990; 82(2):293-303. PubMed ID: 1704847
[TBL] [Abstract][Full Text] [Related]
6. Differential neurotensin responses to low and high doses of methamphetamine in the terminal regions of striatal efferents.
Frankel PS; Hoonakker AJ; Hanson GR; Bush L; Keefe KA; Alburges ME
Eur J Pharmacol; 2005 Oct; 522(1-3):47-54. PubMed ID: 16199030
[TBL] [Abstract][Full Text] [Related]
7. Intranigral substance P stimulation of striatal dopamine release is inhibited by spantide II: a new tachykinin antagonist without apparent neurotoxicity.
Reid MS; Hökfelt T; Herrera-Marschitz M; Håkanson R; Feng DM; Folkers K; Goldstein M; Ungerstedt U
Brain Res; 1990 Nov; 532(1-2):175-81. PubMed ID: 1704289
[TBL] [Abstract][Full Text] [Related]
8. Differential dopaminergic regulation of the neurotensin striatonigral and striatopallidal pathways in the rat.
Castel MN; Morino P; Nylander I; Terenius L; Hökfelt T
Eur J Pharmacol; 1994 Sep; 262(1-2):1-10. PubMed ID: 7813560
[TBL] [Abstract][Full Text] [Related]
9. Nigrostriatal dopamine actions on the D2 receptors mediate methamphetamine effects on the striatonigral substance P system.
Sonsalla PK; Gibb JW; Hanson GR
Neuropharmacology; 1986 Nov; 25(11):1221-30. PubMed ID: 2432440
[TBL] [Abstract][Full Text] [Related]
10. Characterization of methamphetamine effects on the striatal-nigral dynorphin system.
Hanson GR; Merchant KM; Letter AA; Bush L; Gibb JW
Eur J Pharmacol; 1988 Oct; 155(1-2):11-8. PubMed ID: 2907484
[TBL] [Abstract][Full Text] [Related]
11. Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
Wagstaff JD; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1996 Aug; 278(2):547-54. PubMed ID: 8768703
[TBL] [Abstract][Full Text] [Related]
12. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
Reid MS; Herrera-Marschitz M; Hökfelt T; Ohlin M; Valentino KL; Ungerstedt U
Neuroscience; 1990; 36(3):643-58. PubMed ID: 1700329
[TBL] [Abstract][Full Text] [Related]
13. N-Methyl-D-aspartate receptors mediate dopamine-induced changes in extrapyramidal and limbic dynorphin systems.
Singh NA; Midgley LP; Bush LG; Gibb JW; Hanson GR
Brain Res; 1991 Aug; 555(2):233-8. PubMed ID: 1681999
[TBL] [Abstract][Full Text] [Related]
14. Comparison of responses by striatonigral substance P and neurokinin A systems to methamphetamine treatment.
Hanson GR; Letter AA; Merchant K; Gibb JW
Peptides; 1986; 7(6):983-7. PubMed ID: 2436197
[TBL] [Abstract][Full Text] [Related]
15. Effect of methamphetamine on neurotensin concentrations in rat brain regions.
Letter AA; Merchant K; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1987 May; 241(2):443-7. PubMed ID: 3572804
[TBL] [Abstract][Full Text] [Related]
16. Intranigral injection of dynorphin in combination with substance P on striatal dopamine metabolism in the rat.
Tan DP; Tsou K
Brain Res; 1988 Mar; 443(1-2):310-4. PubMed ID: 2451993
[TBL] [Abstract][Full Text] [Related]
17. Effects of intranigral substance P and neurokinin A on striatal dopamine release--II. Interactions with bicuculline and naloxone.
Reid MS; Herrera-Marschitz M; Ungerstedt U
Neuroscience; 1990; 36(3):659-67. PubMed ID: 1700330
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor.
Dang DK; Shin EJ; Kim DJ; Tran HQ; Jeong JH; Jang CG; Nah SY; Jeong JH; Byun JK; Ko SK; Bing G; Hong JS; Kim HC
J Neuroinflammation; 2018 Feb; 15(1):52. PubMed ID: 29467000
[TBL] [Abstract][Full Text] [Related]
19. Substance P-(1-7) and substance P-(5-11) locally modulate dopamine release in rat striatum.
Khan S; Brooks N; Whelpton R; Michael-Titus AT
Eur J Pharmacol; 1995 Aug; 282(1-3):229-33. PubMed ID: 7498281
[TBL] [Abstract][Full Text] [Related]
20. Effect of single and repeated methamphetamine treatment on neurotransmitter release in substantia nigra and neostriatum of the rat.
Bustamante D; You ZB; Castel MN; Johansson S; Goiny M; Terenius L; Hökfelt T; Herrera-Marschitz M
J Neurochem; 2002 Nov; 83(3):645-54. PubMed ID: 12390526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
